Cell Point India Ltd vs Medplus Health Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Cell Point (India) Ltd is ₹ 15 as of 30 Oct 15:30 . The P/E Ratio of Cell Point (India) Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Medplus Health Services Ltd changed from 125.8 on March 2022 to 45.8 on March 2026 . This represents a CAGR of -18.30% over 5 years The Market Cap of Cell Point (India) Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Medplus Health Services Ltd changed from ₹ 12052 crore on March 2022 to ₹ 10057 crore on March 2026 . This represents a CAGR of -3.55% over 5 years The revenue of Cell Point (India) Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Medplus Health Services Ltd for the Sep '26 is ₹ 2057 crore as compare to the Jun '26 revenue of ₹ 1899 crore. This represent the growth of 8.33% The ebitda of Cell Point (India) Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Medplus Health Services Ltd for the Sep '26 is ₹ 190.6 crore as compare to the Jun '26 ebitda of ₹ 153.07 crore. This represent the growth of 24.52% The net profit of Cell Point (India) Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of Medplus Health Services Ltd changed from ₹ 14.34 crore to ₹ 56.07 crore over 10 quarters. This represents a CAGR of 72.53% The Dividend Payout of Cell Point (India) Ltd changed from 27.65 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Medplus Health Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Cell Point (India) Ltd

Cell Point (India) Limited was formerly incorporated as 'Cell Point (India) Private Limited' on April 10, 2013 as a Private Company with Registrar of Companies, Andhra Pradesh.
The Company was subsequently converted into a public Company vide fresh Certificate of Incorporation dated November 25, 2022.
The Promoters started business as small mobile retailers in Vizag, Vishakhapatnam, Andhra Pradesh in 2001 and took over the running businesses of sole Proprietary Concerns of the Promoters, M/s.
Cell Point and M/s.
Mobile King as a going concern basis with all of their respective assets and liabilities. The Company currently sells all its products directly through 75 stores spread across Andhra Pradesh, of which 2 stores are owned properties and 73 stores are on leased properties.

About Medplus Health Services Ltd

MedPlus Health Services Limited was incorporated as a Private Company as 'MedPlus Health Services Private Limited' at Hyderabad on 30 November, 2006.
The Company converted its status from a Private to a Public Company and name of the Company was changed to MedPlus Health Services Limited on 28 June 2021. The Company is primarily engaged in the business of provision of diagnostic services, pathological services and laboratory testing services.
Further, the Company is also engaged in the manufacturing, purchase and sale of pharmaceuticals and other general items and rendering of management services to group companies.
The Company now has 12 Diagnostics Centers in Hyderabad. On 21 January 2021, the Company has issued and allotted 254674 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 1.

FAQs for the comparison of Cell Point (India) Ltd and Medplus Health Services Ltd

Which company has a larger market capitalization, Cell Point (India) Ltd or Medplus Health Services Ltd?

Market cap of Cell Point (India) Ltd is 28 Cr while Market cap of Medplus Health Services Ltd is 6,966 Cr

What are the key factors driving the stock performance of Cell Point (India) Ltd and Medplus Health Services Ltd?

The stock performance of Cell Point (India) Ltd and Medplus Health Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cell Point (India) Ltd and Medplus Health Services Ltd?

As of November 1, 2026, the Cell Point (India) Ltd stock price is INR ₹15.0. On the other hand, Medplus Health Services Ltd stock price is INR ₹579.8.

How do dividend payouts of Cell Point (India) Ltd and Medplus Health Services Ltd compare?

To compare the dividend payouts of Cell Point (India) Ltd and Medplus Health Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.